Cardiovascular manifestations of the emerging dengue pandemic

[1]  Victor A Convertino,et al.  Running on empty? The compensatory reserve index , 2013, The journal of trauma and acute care surgery.

[2]  J. Farrar,et al.  Corticosteroids for Dengue – Why Don't They Work? , 2013, PLoS neglected tropical diseases.

[3]  N. M. Dung,et al.  Clinical Characteristics of Dengue Shock Syndrome in Vietnamese Children: A 10-Year Prospective Study in a Single Hospital , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Saggioro,et al.  Evaluation of cardiac involvement during dengue viral infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Bestetti,et al.  Fulminant myocarditis and viral infection. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  Zhining Wang,et al.  Sequential Waves of Gene Expression in Patients with Clinically Defined Dengue Illnesses Reveal Subtle Disease Phases and Predict Disease Severity , 2013, PLoS neglected tropical diseases.

[7]  S. Inoue,et al.  Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar , 2013, Journal of medical virology.

[8]  Sophie Yacoub,et al.  The pathogenesis of dengue , 2013, Current opinion in infectious diseases.

[9]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[10]  Shivananda,et al.  Ultrasonography as a tool in predicting the severity of dengue fever in children—a useful aid in a developing country , 2013, Pediatric Radiology.

[11]  M. Rossi,et al.  A case presentation of a fatal dengue myocarditis showing evidence for dengue virus-induced lesion , 2013, European heart journal. Acute cardiovascular care.

[12]  L. Cooper,et al.  Speckle tracking echocardiography in acute myocarditis , 2013, The International Journal of Cardiovascular Imaging.

[13]  D. Libraty,et al.  Dengue Virus Type 2 Modulates Endothelial Barrier Function through CD73 , 2013, The American journal of tropical medicine and hygiene.

[14]  D. Broadway,et al.  Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management , 2012, BMC Ophthalmology.

[15]  R. Peeling,et al.  Lovastatin for adult patients with dengue: protocol for a randomised controlled trial , 2012, Trials.

[16]  C. T. Tam,et al.  Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Jairo A. Rodríguez,et al.  Use of Pentoxifylline in Treatment of Children With Dengue Hemorrhagic Fever , 2012, The Pediatric infectious disease journal.

[18]  V. Herasevich,et al.  Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. , 2012, Mayo Clinic proceedings.

[19]  Marcel Wolbers,et al.  Clinical Features of Dengue in a Large Vietnamese Cohort: Intrinsically Lower Platelet Counts and Greater Risk for Bleeding in Adults than Children , 2012, PLoS neglected tropical diseases.

[20]  Cameron P. Simmons,et al.  Current concepts: Dengue , 2012 .

[21]  F. Curry,et al.  Endothelial Glycocalyx: Permeability Barrier and Mechanosensor , 2012, Annals of Biomedical Engineering.

[22]  Eli Schwartz,et al.  Capillary leakage in travelers with dengue infection: implications for pathogenesis. , 2012, The American journal of tropical medicine and hygiene.

[23]  J. Farrar,et al.  Cardiac function in Vietnamese patients with different dengue severity grades* , 2012, Critical care medicine.

[24]  F. Roubille,et al.  Acute pericarditis after dengue fever. , 2011, Annales de cardiologie et d'angeiologie.

[25]  S. Gunasena,et al.  Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009 , 2011, BMC Research Notes.

[26]  A. Khongphatthanayothin,et al.  Spectrum of cardiac rhythm abnormalities and heart rate variability during the convalescent stage of dengue virus infection: a Holter study , 2011, Annals of tropical paediatrics.

[27]  H. Schatzmayr,et al.  A New Approach to Dengue Fatal Cases Diagnosis: NS1 Antigen Capture in Tissues , 2011, PLoS neglected tropical diseases.

[28]  Richard G. Jarman,et al.  Determinants of Inapparent and Symptomatic Dengue Infection in a Prospective Study of Primary School Children in Kamphaeng Phet, Thailand , 2011, PLoS neglected tropical diseases.

[29]  M. Martínez-Gutiérrez,et al.  Statins Reduce Dengue Virus Production via Decreased Virion Assembly , 2011, Intervirology.

[30]  G. Screaton,et al.  Immunodominant T-cell responses to dengue virus NS3 are associated with DHF , 2010, Proceedings of the National Academy of Sciences.

[31]  S. Rajpal,et al.  Spontaneous resolution of sinoatrial exit block and atrioventricular dissociation in a child with dengue fever. , 2010, Singapore medical journal.

[32]  J. Vincent,et al.  Monitoring the microcirculation in the critically ill patient: current methods and future approaches , 2010, Intensive Care Medicine.

[33]  J. Farrar,et al.  A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.

[34]  J. Levick,et al.  Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.

[35]  Keith Mansfield,et al.  Heart and Skeletal Muscle Are Targets of Dengue Virus Infection , 2010, The Pediatric infectious disease journal.

[36]  J. Farrar,et al.  Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. , 2009, The American journal of tropical medicine and hygiene.

[37]  S. Halstead,et al.  Assessing the prognosis of dengue-infected patients , 2009, F1000 medicine reports.

[38]  Ramy Arnaout,et al.  Customized care 2020: how medical sequencing and network biology will enable personalized medicine , 2009, F1000 biology reports.

[39]  Y. Chan,et al.  Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[40]  M. Su,et al.  Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  Chi‐Hang Lee,et al.  Fulminant dengue myocarditis masquerading as acute myocardial infarction. , 2009, International journal of cardiology.

[42]  F. Ennis,et al.  Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. , 2009, The Journal of infectious diseases.

[43]  P. Friedl,et al.  Peptide Bβ15-42 Preserves Endothelial Barrier Function in Shock , 2009, PloS one.

[44]  J. Statler,et al.  Sonographic findings of healthy volunteers infected with dengue virus , 2008, Journal of clinical ultrasound : JCU.

[45]  M. Diamond,et al.  Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E , 2007, PLoS pathogens.

[46]  A. Khongphatthanayothin,et al.  Myocardial depression in dengue hemorrhagic fever: Prevalence and clinical description* , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[47]  Y. Poovorawan,et al.  The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection , 2007, Annals of tropical paediatrics.

[48]  Sheyla Silva,et al.  ULTRASOUND MEASUREMENT OF GALLBLADDER WALL THICKENING AS A DIAGNOSTIC TEST AND PROGNOSTIC INDICATOR FOR SEVERE DENGUE IN PEDIATRIC PATIENTS , 2007, The Pediatric infectious disease journal.

[49]  M. Merx,et al.  Sepsis and the heart. , 2007, Circulation.

[50]  S. Gunasena,et al.  Cardiac complications of a dengue fever outbreak in Sri Lanka, 2005. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[51]  Yan-Ping Tian,et al.  Up-regulated expression of beta3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells. , 2007, Biochemical and biophysical research communications.

[52]  P. Tambyah,et al.  Dengue and Relative Bradycardia , 2007, Emerging infectious diseases.

[53]  A. Nisalak,et al.  Natural History of Plasma Leakage in Dengue Hemorrhagic Fever: A Serial Ultrasonographic Study , 2007, The Pediatric infectious disease journal.

[54]  Tucson,et al.  Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. , 2007, British journal of anaesthesia.

[55]  S. Kalayanarooj,et al.  Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.

[56]  L. Cooper,et al.  Noninvasive imaging in myocarditis. , 2006, Journal of the American College of Cardiology.

[57]  S. Yoksan,et al.  Elevated Soluble Thrombomodulin in the Febrile Stage Related to Patients at Risk for Dengue Shock Syndrome , 2006, The Pediatric infectious disease journal.

[58]  V. Kolb-Bachofen,et al.  The role of nitric oxide. , 2006, Rheumatology.

[59]  A. Rothman,et al.  Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. , 2006, Endothelium : journal of endothelial cell research.

[60]  M. Blettner,et al.  Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.

[61]  J. Lusher,et al.  Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection , 2005, Thrombosis and Haemostasis.

[62]  Y. Poovorawan,et al.  HEPATOSPLANCHNIC CIRCULATORY DYSFUNCTION IN ACUTE HEPATIC INFECTION: THE CASE OF DENGUE HEMORRHAGIC FEVER , 2005, Shock.

[63]  Denis Chemla,et al.  Clinical review: Interpretation of arterial pressure wave in shock states , 2005, Critical care.

[64]  Akira Igarashi,et al.  Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. , 2005, The American journal of tropical medicine and hygiene.

[65]  A. Rothman,et al.  Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. , 2005, Cytokine.

[66]  N. M. Dung,et al.  Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.

[67]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[68]  K. Wong,et al.  Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. , 2004, The Journal of infectious diseases.

[69]  Stephen C. Cowin,et al.  Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  H. Schultheiss,et al.  Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .

[71]  J. Rigau-Pérez,et al.  Dengue severity in the elderly in Puerto Rico. , 2003, Revista panamericana de salud publica = Pan American journal of public health.

[72]  J. Gamble,et al.  Supernatants from dengue virus type‐2 infected macrophages induce permeability changes in endothelial cell monolayers , 2003, Journal of medical virology.

[73]  P. Bhattarakosol,et al.  Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: an echocardiographic study , 2003, Intensive Care Medicine.

[74]  Yee‐Shin Lin,et al.  Antibodies from dengue patient sera cross‐react with endothelial cells and induce damage , 2003, Journal of medical virology.

[75]  Yee‐Shin Lin,et al.  Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide , 2002, The Journal of Immunology.

[76]  N. M. Dung,et al.  Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  Alan L Rothman,et al.  Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. , 2002, American journal of epidemiology.

[78]  Wei Zhang,et al.  Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.

[79]  B. Murgue,et al.  Plasma concentrations of sVCAM‐1 and severity of dengue infections , 2001, Journal of medical virology.

[80]  I. Gartside,et al.  Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  P. Chotivitayatarakorn,et al.  Morbitz type I second degree AV block during recovery from dengue hemorrhagic fever. , 2000, The Southeast Asian journal of tropical medicine and public health.

[82]  V. Monroy,et al.  Participation of the Dengue Virus in the Fibrinolytic Process , 2000, Virus Genes.

[83]  I. Gartside,et al.  Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? , 2000, Clinical science.

[84]  A. Pacsa,et al.  Sequential production of cytokines by dengue virus‐infected human peripheral blood leukocyte cultures , 1999, Journal of medical virology.

[85]  B. Seliger,et al.  Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. , 1998, Journal of immunology.

[86]  N. Wig,et al.  Cardiac involvement in Dengue Haemorrhagic Fever. , 1998, International journal of cardiology.

[87]  S. Kothari,et al.  Myocardial dysfunction in children with dengue haemorrhagic fever. , 1998, The National medical journal of India.

[88]  J. Esko,et al.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.

[89]  S. Rojanasuphot,et al.  Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. , 1993, Pediatrics.

[90]  B. Pongpanich,et al.  Hemostatic derangement in dengue haemorrhagic fever. , 1987, The Southeast Asian journal of tropical medicine and public health.

[91]  D. Gubler,et al.  Dengue shock syndrome in an American traveler with primary dengue 3 infection. , 1987, The American journal of tropical medicine and hygiene.

[92]  T. Chirachariyavej,et al.  Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. , 1980, The Southeast Asian journal of tropical medicine and public health.

[93]  I. Obeyesekere,et al.  Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever). , 1972, British heart journal.

[94]  R. Siegel,et al.  Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .

[95]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[96]  P. Chandraratna,et al.  An Echocardiographic Study , 2015 .

[97]  Fredric Ginsberg,et al.  Fulminant myocarditis. , 2013, Critical care clinics.

[98]  Y. Leo,et al.  Dengue myocarditis in Singapore: two case reports , 2012, Infection.

[99]  B. Wills,et al.  Systemic vascular leakage associated with dengue infections - the clinical perspective. , 2010, Current topics in microbiology and immunology.

[100]  H. Schatzmayr,et al.  A retrospective survey of dengue virus infection in fatal cases from an epidemic in Brazil. , 2009, Journal of virological methods.

[101]  C. Ker,et al.  Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. , 2005, FEMS immunology and medical microbiology.

[102]  B. Vandermeer,et al.  Intravenous immunoglobulin for presumed viral myocarditis in children and adults. , 2005, The Cochrane database of systematic reviews.

[103]  Worakan Promphan,et al.  Dengue myocarditis. , 2004, The Southeast Asian journal of tropical medicine and public health.

[104]  Abdulmajeed Al Abdukareem.  Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.

[105]  H. Schultheiss,et al.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.

[106]  Joyce Morgana Braga de Paiva,et al.  Acute atrial fibrillation during dengue hemorrhagic fever. , 2003, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[107]  Melani W. Setiawan,et al.  Dengue haemorrhagic fever: ultrasound as an aid to predict the severity of the disease , 1998, Pediatric Radiology.

[108]  R. Reed,et al.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.